SNM to showcase the latest research in molecular imaging and nuclear medicine

November 03, 2008

Reston, Va.--SNM invites scientific investigators to submit abstracts to present their research at the society's 56th Annual Meeting--the world's largest event dedicated to molecular imaging and nuclear medicine--June 13-17, 2009, in Toronto, Canada.

"The emerging field of molecular imaging is vital and state-of-the-art," said SNM President Robert Atcher, Ph.D., M.B.A., who represents the society's more than 17,000 molecular imaging and nuclear medicine professionals. "At SNM's Annual Meeting, researchers from around the world come together to present the most leading-edge research in the field today--research that will help make personalized medicine a reality."

"This meeting offers researchers the ideal opportunity to present their work at an international forum of nuclear medicine and molecular imaging professionals," explained Frederic H. Fahey, D.Sc., chair of SNM's Scientific Program Committee and director of nuclear medicine/PET physics at Children's Hospital, Boston, Mass. "Not only will presenting authors be able to highlight their work--they will also be able to hear about other exciting research being performed in molecular imaging around the world," Fahey added. More than 1,800 abstracts will be presented from authors in 80 countries during the five-day event.

The SNM scientific abstracts program encompasses nine tracks: cardiovascular, neuroscience, oncology-basic, oncology-clinical diagnosis, general clinical specialties, instrumentation and data analysis, radiopharmaceutical chemistry, multimodality and nonradioactive molecular imaging. Additionally, the meeting offers InfoSNM computer presentations, educational exhibits and technologist and technologist student presentations. Medical students, fellows and young physicians (less than three years out of training) are encouraged to submit their work for the prestigious Young Investigator and Young Professional Committee Awards and to apply for abstract-related travel awards upon notification of abstract acceptance in March 2009. Interested authors may submit abstracts demonstrating the economic value of molecular imaging for patient management in consideration for the Siemens Award for Excellence in Practice-Based Research.

Online abstract submission for 2009 SNM Annual Meeting begins Nov. 3, 2008, and is open through Jan. 13, 2009. For more information, visit www.snm.org/abstracts.

Registration for SNM's 56th Annual Meeting is free for members of the press or freelancers with a letter of assignment.
-end-
About SNM

SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.

Society of Nuclear Medicine

Related Molecular Imaging Articles from Brightsurf:

New technique offers higher resolution molecular imaging and analysis
The new approach from Northwestern Engineering could help researchers understand more complicated biomolecular interactions and characterize cells and diseases at the single-molecule level.

Molecular imaging offers insight into therapy outcomes for neuroendocrine tumor patients
A new proof-of-concept study published in the May issue of The Journal of Nuclear Medicine has demonstrated that molecular imaging can be used for identifying early response to 177Lu-DOTATATE treatment in neuroendocrine tumor patients.

Non-invasive imaging method spots cancer at the molecular level
Researchers for the first time have combined a powerful microscopy technique with automated image analysis algorithms to distinguish between healthy and metastatic cancerous tissue without relying on invasive biopsies or the use of a contrast dye.

Molecular imaging suggests smokers may have impaired neuroimmune function
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.

Novel noninvasive molecular imaging for monitoring rheumatoid arthritis
A first-in-human Phase 1/Phase II study demonstrates that intravenous administration of the radiopharmaceutical imaging agent technetium-99m (99mTc) tilmanocept promises to be a safe, well-tolerated, noninvasive means of monitoring rheumatoid arthritis disease activity.

Improving molecular imaging using a deep learning approach
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed using a new deep learning approach to image reconstruction developed by researchers at Rensselaer Polytechnic Institute.

Nanoplatform developed with three molecular imaging modalities for tumor diagnosis
Nanotechnology and biotechnology are bringing us increasingly closer to personalised cancer treatment.

Study suggests molecular imaging strategy for determining molecular classifications of NSCLC
Recent findings suggest a novel positron emission tomography (PET) imaging approach determining epidermal growth factor receptor (EGFR) mutation status for improved lung cancer patient management.

New imaging technique able to watch molecular dynamics of neurodegenerative diseases
Researchers have developed a fast and practical molecular-scale imaging technique that could let scientists view never-before-seen dynamics of biological processes involved in neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

Combined optical and molecular imaging could guide breast-conserving surgery
Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

Read More: Molecular Imaging News and Molecular Imaging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.